Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr:153:155813.
doi: 10.1016/j.metabol.2024.155813. Epub 2024 Feb 1.

Intermittent fasting protects β-cell identity and function in a type-2 diabetes model

Affiliations

Intermittent fasting protects β-cell identity and function in a type-2 diabetes model

Sumit Patel et al. Metabolism. 2024 Apr.

Abstract

Type 2 diabetes (T2DM) is caused by the interaction of multiple genes and environmental factors. T2DM is characterized by hyperglycemia, insulin secretion deficiency and insulin resistance. Chronic hyperglycemia induces β-cell dysfunction, loss of β-cell mass/identity and β-cell dedifferentiation. Intermittent fasting (IF) a commonly used dietary regimen for weight-loss, also induces metabolic benefits including reduced blood glucose, improved insulin sensitivity, reduced adiposity, inflammation, oxidative-stress and increased fatty-acid oxidation; however, the mechanisms underlying these effects in pancreatic β-cells remain elusive. KK and KKAy, mouse models of polygenic T2DM spontaneously develop hyperglycemia, glucose intolerance, glucosuria, impaired insulin secretion and insulin resistance. To determine the long-term effects of IF on T2DM, 6-weeks old KK and KKAy mice were subjected to IF for 16 weeks. While KKAy mice fed ad-libitum demonstrated severe hyperglycemia (460 mg/dL) at 6 weeks of age, KK mice showed blood glucose levels of 230 mg/dL, but progressively became severely diabetic by 22-weeks. Strikingly, both KK and KKAy mice subjected to IF showed reduced blood glucose and plasma insulin levels, decreased body weight gain, reduced plasma triglycerides and cholesterol, and improved insulin sensitivity. They also demonstrated enhanced expression of the β-cell transcription factors NKX6.1, MAFA and PDX1, and decreased expression of ALDH1a3 suggesting protection from loss of β-cell identity by IF. IF normalized glucose stimulated insulin secretion in islets from KK and KKAy mice, demonstrating improved β-cell function. In addition, hepatic steatosis, gluconeogenesis and inflammation was decreased particularly in KKAy-IF mice, indicating peripheral benefits of IF. These results have important implications as an optional intervention for preservation of β-cell identity and function in T2DM.

Keywords: Diabetes; Identity; Insulin; Intermittent fasting; Metabolism; beta-cell.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors have declared that no conflict of interest exists. Dr. Maria Remedi is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Similar articles

Cited by

References

    1. Weir GC, Bonner-Weir S. Islet beta cell mass in diabetes and how it relates to function, birth, and death. Ann N Y Acad Sci 2013;1281:92–105. - PMC - PubMed
    1. Cantley J, Ashcroft FM. Q&A: insulin secretion and type 2 diabetes: why do β-cells fail? BMC Biology 2015;13. - PMC - PubMed
    1. Cinti F, Bouchi R, Kim-Muller JY, Ohmura Y, Rodrigo Sandoval P, Masini M, et al. Evidence of beta-cell Dedifferentiation in Human Type 2 Diabetes. J Clin Endocrinol Metab 2015;101:1044–54. - PMC - PubMed
    1. Guo S, Dai C, Guo M, Taylor B, Harmon JS, Sander M, et al. Inactivation of specific beta cell transcription factors in type 2 diabetes. J Clin Invest 2013;123:3305–16. - PMC - PubMed
    1. Butler AE, Dhawan S, Hoang J, Cory M, Zeng K, Fritsch H, et al. beta-Cell Deficit in Obese Type 2 Diabetes, a Minor Role of beta-Cell Dedifferentiation and Degranulation. J Clin Endocrinol Metab 2016;101:523–32. - PMC - PubMed

LinkOut - more resources